Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -122,545 | -114,593 | -28,607 | -18,522 | -7,291 |
| Depreciation Amortization | 459 | 336 | 212 | 95 | 98 |
| Accounts receivable | -659 | 5 | 5 | 4 | N/A |
| Other Working Capital | -2,291 | -1,355 | 1,175 | -785 | -999 |
| Other Operating Activity | 101,548 | 98,951 | 16,981 | 15,778 | 91 |
| Operating Cash Flow | $-23,488 | $-16,656 | $-10,234 | $-3,430 | $-8,101 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -154 | -7 | N/A | N/A | -39 |
| Net Acquisitions | -22,707 | -22,707 | 147 | 148 | N/A |
| Other Investing Activity | 119 | 119 | 119 | 119 | 0 |
| Investing Cash Flow | $-22,742 | $-22,595 | $266 | $267 | $-39 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 310 |
| Debt Repayment | -942 | -532 | -532 | -532 | N/A |
| Common Stock Issued | 62,535 | 64,616 | 59,035 | 10,475 | 4,359 |
| Dividend Paid | -8 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -2,080 | 0 | 0 | 0 |
| Financing Cash Flow | $61,585 | $62,004 | $58,503 | $9,943 | $4,669 |
| Beginning Cash Position | 1,630 | 1,630 | 1,630 | 1,630 | 5,101 |
| End Cash Position | 16,985 | 24,383 | 50,165 | 8,410 | 1,630 |
| Net Cash Flow | $15,355 | $22,753 | $48,535 | $6,780 | $-3,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,488 | -16,656 | -10,234 | -3,430 | -8,101 |
| Capital Expenditure | -154 | -7 | N/A | N/A | -39 |
| Free Cash Flow | -23,642 | -16,663 | -10,234 | -3,430 | -8,140 |